Drug intelligence / Profile preview

isolinderalactone

Development stage
Preclinical
Modality
Small Molecules
01

Overview

Isolinderalactone is a naturally occurring sesquiterpene lactone isolated from the root extract of *Lindera aggregata*. Preclinical publications describe it as an experimental small molecule with antineoplastic activity in cancer cell models, including colorectal cancer. In colorectal cancer cell lines, isolinderalactone has been reported to suppress proliferation and induce reactive oxygen species mediated stress responses leading to G2/M cell-cycle arrest, mitochondrial apoptosis, autophagy, and MAPK pathway activation. It does not appear to be an approved medicine or a clinically developed pharmaceutical product, and no specific commercial developer or manufacturer is clearly established from the provided evidence.

Other names
isolinderalactoneILL
02

Targets

CCNB1 (Cyclin B1)CDK1 (Cyclin-dependent kinase 1)CDC25C (Cell division cycle 25C phosphatase)CDKN1A (Cyclin-dependent kinase inhibitor 1A)MAP1LC3ACASP3 (Caspase-3)CASP9 (Caspase-9)MAPK3 (Mitogen-activated protein kinase 1)

Beyond the preview

Go deeper on isolinderalactone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on isolinderalactone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call